| Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease JA Woods, JS Wheeler, CK Finch, NA Pinner International journal of chronic obstructive pulmonary disease, 421-430, 2014 | 122 | 2014 |
| Impact of distance education via interactive videoconferencing on students’ course performance and satisfaction OM Klibanov, C Dolder, K Anderson, HA Kehr, JA Woods Advances in physiology education 42 (1), 21-25, 2018 | 51 | 2018 |
| Matrix remodeling expression in anulus cells subjected to increased compressive load KH Wenger, JA Woods, A Holecek, EC Eckstein, JT Robertson, KA Hasty Spine 30 (10), 1122-1126, 2005 | 49 | 2005 |
| Cannabinoid hyperemesis syndrome: an emerging drug-induced disease JA Woods, NJD Wright, J Gee, MW Scobey American Journal of Therapeutics 23 (2), e601-e605, 2016 | 33 | 2016 |
| Strategies to preserve the use of statins in patients with previous muscular adverse effects KM Reinhart, JA Woods American Journal of Health-System Pharmacy 69 (4), 291-300, 2012 | 28 | 2012 |
| Low‐Dose Naloxone for Prophylaxis of Postoperative Nausea and Vomiting: A Systematic Review and Meta‐analysis RW Barrons, JA Woods Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (5 …, 2017 | 24 | 2017 |
| Opportunities for inhaler device selection in elderly patients with asthma or COPD R Barrons, J Wheeler, JA Woods Patient Intelligence, 53-65, 2015 | 19 | 2015 |
| Less is more: Exploring the value of micro-credentials within a graduate program K Woods, JA Woods The Journal of Continuing Higher Education 71 (2), 215-223, 2023 | 17 | 2023 |
| Aclidinium bromide: an alternative long-acting inhaled anticholinergic in the management of chronic obstructive pulmonary disease JA Woods, KL Nealy, RW Barrons Annals of Pharmacotherapy 47 (7-8), 1017-1028, 2013 | 12 | 2013 |
| A review of ceftolozane/tazobactam for the treatment of infections caused by multidrug-resistant pathogens J Sebaaly, JA Woods, KA Wargo Infectious Diseases in Clinical Practice 26 (4), 198-203, 2018 | 10 | 2018 |
| Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team AN Amin, S Cornelison, JA Woods, NA Hanania Postgraduate Medicine 134 (2), 152-159, 2022 | 7 | 2022 |
| An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations. JA Woods, JB Usery, TH Self, CK Finch Southern medical journal 104 (11), 742-745, 2011 | 7 | 2011 |
| Evidence-based treatment during the SARS-CoV-2 pandemic: identifying the knowns and unknowns of nebulization JA Woods Journal of the American Pharmacists Association 61 (2), e55-e56, 2021 | 6 | 2021 |
| Delayed presentation of hepatocellular liver injury after nintedanib administration JL Olin, JA Woods, SJ Garner American Journal of Therapeutics 24 (1), e107-e108, 2017 | 6 | 2017 |
| The roles of ACE inhibitors in lower extremity peripheral artery disease RW Barrons, JA Woods American Journal of Therapeutics 23 (1), e7-e15, 2016 | 5 | 2016 |
| Statin Associated Autoimmune Myonecrosis: Case Report With Delayed Onset and Treatment Challenges R Barrons, JA Woods, R Humphries Journal of Pharmacy Practice 35 (1), 129-134, 2022 | 2 | 2022 |
| Managing drug-resistant organisms in acute care KL Nealy, DJ McCarty, JA Woods Nursing2020 Critical Care 11 (3), 16-22, 2016 | 2 | 2016 |
| Investigating primary and secondary school staff views on the level of need for educational psychology services in England:“What does good look like?” T Hooper, K Woods, K Fallon, H Chilton, R Dennis, A Sedgwick, J Suchy, ... Educational Psychology in Practice 40 (2), 220-236, 2024 | 1 | 2024 |
| Respiratory Syncytial Virus Vaccines for the Prevention of Lower Respiratory Tract Infections in Patients Living with Chronic Obstructive Pulmonary Disease: A Rapid Review PM Boylan, ME Fleischman, N Pinner, JA Woods, A Welch Biologics 4 (1), 17-29, 2024 | | 2024 |
| Depression in COPD: Does Antidepressant Use Influence Rate of Exacerbation or Early Hospital Readmission? JA Woods, R Owens, J Sebaaly, B Harris, R Barrons C41. EPIDEMIOLOGY AND COMORBIDITIES IN COPD, A5107-A5107, 2020 | | 2020 |
